ArticleFrontiers in microbiology2026
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
[NiFe] hydrogenases reversibly catalyze hydrogen oxidation and proton reduction at a Ni-Fe active site coordinated by four cysteine (Cys) residues in two CXXC motifs within the catalytic large subunit. A subset of these enzymes contains selenocysteine (Sec) in place of Cys in the C-terminal CXXC motif, forming [NiFeSe] hydrogenases with enhanced oxygen tolerance and hydrogen production activity. However, such Sec-containing variants have been reported only in Groups 1 and 3 [NiFe] hydrogenases. Here, we present a comprehensive dataset of Group 4 [NiFeSe] hydrogenases based on a genomic survey combined with UGA stop-codon read-through analysis. The dataset comprises 47 non-redundant protein sequences from nine bacterial phyla. Sec substitutions were exclusively identified in the N-terminal CXXC motif, including 27 CXXU-, 4 UXXC-, and 16 UXXU-type sequences, indicating the emergence of non-canonical Sec-containing motifs in Group 4. Phylogenetic analysis revealed a sporadic distribution across three distinct lineages, indicating at least three independent origins of Sec-containing variants from Cys-type ancestors. Such substitutions were found across diverse ecosystems. Genomic context analysis further suggests that these Sec-containing enzymes form energy-converting complexes, similar to those formed by other Group 4 enzymes. The Sec-containing variants co-occur with Sec biosynthesis genes and a conserved guanine residue in the apical loop of Sec insertion sequence elements. These findings provide new insights into the evolution of Sec utilization in [NiFe] hydrogenases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.